Tim Anderson - Can we prevent Alzheimer's dementia?



Published
Brain Health Matters - 13 July 2022, Manawa Building

Professor Tim Anderson will outline a new world-wide drug trial available to people in Canterbury aged 60 to 80 years of age with normal memory and thinking but at risk of future Alzheimer's dementia.

About the New Zealand Brain Research Institute
We are the only independent brain research institute in New Zealand and we’re working on finding the answers to the complex questions surrounding conditions affecting the brain. We work collaboratively with the Universities of Canterbury and Otago, the Canterbury District Health Board and others, to run high quality research and offer research opportunities to both emerging and established researchers from all over the world.

Based in Christchurch, the New Zealand Brain Research Institute improves brain-health through research, education and clinical practice. Our work includes:
- Research into the effects and treatments for New Zealand’s most common brain disorders, including Parkinson’s disease, dementia, Alzheimer’s, Huntington’s and multiple sclerosis;
- Fostering promising, young, graduate students to train as researchers;
- Hosting neurology clinics for movement disorders such as Parkinson’s disease and Huntington’s, as well as for cognitive problems (e.g. dementia and mild cognitive impairment); and
- Educating the wider community about brain-health and research outcomes.
Category
Job
Be the first to comment